Alkem Laboratories

Alkem Laboratories Limited
Type	Public
Traded as	BSE: 539523; NSE: ALKEM
Industry	Pharmaceuticals
Founded	1973
Founder	Samprada Singh
Headquarters	Mumbai, Maharashtra, India
Key people	Samprada Singh, Dhananjay Kumar Singh
Products	Pharmaceuticals, generic drugs
Revenue	₹130 billion (US$1.8 billion) (2014-15)[1]
Operating income	₹31.82 billion (US$450 million) (2014–15)
Net income	₹11.44 billion (US$160 million) (2014–15)
Total assets	₹41.75 billion (US$590 million) (2014–15)
Total equity	₹13.5 billion (US$190 million) (2014–15)
Owner	Samprada Singh
Number of employees	15,000 (2015)
Website	www.alkemlabs.com

Alkem Laboratories Limited is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India.

Company

Alkem set up its research and development facility for ANDA development at Taloja in 2003. In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. In 2014 Clavam other drug from Alkem crossed 2,000 million mark in terms of domestic sales in India. In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.

Acquisitions

Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014 acquired the "Clindac-A" brand in India from Galderma S.A. In 2015 again Alkem acquired a formulation manufacturing facility in the US.

Governance and administration

Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com degree from Patna University. He was the 42nd richest person in India and a billionaire.[2] His brother, Basudeo Narayan Singh,[3] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[4]

Position	Name
Founder Chairman Emeritus	Mr. Samprada Singh
Executive Chairman	Mr.Basudeo Narayan Singh
Joint Managing Director	Mr.Dhananjay Kumar Singh
Joint Managing Director	Mr.Sandeep Singh
Independent Director	Dr.Dheeraj Sharma
Independent Director	Mr.A.K. Purwar
Independent Director	Mr.N. K. Aneja
Independent Director	Mr.R. L. Shenoy
Independent Director	Ms.Sangeeta Singh
Independent Director	Ms.Sudha Ravi

[5]

gollark: <:Stick:516249153257340939>

gollark: Er, sticks.

gollark: Discord's not got actual trees, you see.

gollark: 🌴

gollark: Stick currently, but it can be de-electrified if a chapter is written.

References

"Alkem Laboratories Ltd. profit and loss (P&L), financial statement, accounts". rediff.com.
"Samprada Singh & family". Forbes.
"Basudeo Singh". Bloomberg.
"Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.
"Board of Directors". Alkem.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Alkem Laboratories Ltd. profit and loss (P&L), financial statement, accounts". rediff.com.

[2] "Samprada Singh & family". Forbes.

[3] "Basudeo Singh". Bloomberg.

[4] "Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.

[5] "Board of Directors". Alkem.